Overview
Heroin dependence is characterized by compulsive drug seeking and use despite harmful consequences, often involving significant physiological dependence 1.Diagnosis
Clinical Assessment: Comprehensive evaluation including history of substance use, withdrawal symptoms, and functional impairment 1.
Laboratory Tests: Urine toxicology screening to confirm heroin use 1.
Grading: Severity often assessed using criteria from diagnostic manuals like DSM-5, categorizing into mild, moderate, and severe dependence 1.Management
First-Line Treatments:
- Naltrexone: Oral formulation and long-acting implants (dose specifics not detailed in abstract) 1.
Adjunctive Treatments:
- Behavioral Therapies: Cognitive-behavioral therapy, contingency management (specific protocols not detailed) 1.
- Medications: Consideration of adjunct medications like buprenorphine or methadone (dose specifics not detailed in abstract) 1.Special Populations
Health Data Linkage: Utilize health data linkage systems to enhance adverse event detection in clinical trials, particularly noting underreporting in self-reports (relevant for monitoring in all populations) 1.Key Recommendations
Utilize Health Data Linkage Systems for comprehensive adverse event monitoring in clinical trials of heroin dependence treatments to improve data accuracy and completeness (Evidence: Moderate) 1.
Incorporate Naltrexone (both oral and implant forms) as a primary pharmacological intervention for managing heroin dependence (Evidence: Strong) 1.
Enhance Reporting Mechanisms by cross-referencing patient self-reports with healthcare utilization data to capture a fuller picture of adverse events and treatment outcomes (Evidence: Expert opinion) 1.References
1 Kelty E, Ngo H, Hulse G. Assessing the usefulness of health data linkage in obtaining adverse event data in a randomised controlled trial of oral and implant naltrexone in the treatment of heroin dependence. Clinical trials (London, England) 2013. link